JP2000507596A5 - - Google Patents

Download PDF

Info

Publication number: JP2000507596A5
Authority: JP; Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

JP1997535610A

Other languages

English (en)

Japanese (ja)

Other versions

JP2000507596A (ja

Filing date

1997-04-02

Publication date

2004-12-09

1997-04-02 Application filed filed Critical

1997-04-02 Priority claimed from PCT/US1997/005597 external-priority patent/WO1997037005A1/en

2000-06-20 Publication of JP2000507596A publication Critical patent/JP2000507596A/ja

2004-12-09 Publication of JP2000507596A5 publication Critical patent/JP2000507596A5/ja

Status Withdrawn legal-status Critical Current

Links

JP9535610A 1996-04-02 1997-04-02 Ｃｄ４▲上＋▼細胞のｈｉｖ―１感染を防ぐ方法 Withdrawn JP2000507596A (ja)

Applications Claiming Priority (7)

Application Number	Priority Date	Filing Date	Title
US62768496A	1996-04-02	1996-04-02
US08/627,684		1996-04-02
US66361696A	1996-06-14	1996-06-14
US08/663,616		1996-06-14
US67368296A	1996-06-25	1996-06-25
US08/673,682		1996-06-25
PCT/US1997/005597 WO1997037005A1 (en)	1996-04-02	1997-04-02	Method for preventing hiv-1 infection of cd4+ cells

Related Child Applications (1)

Application Number	Title	Priority Date	Filing Date
JP2007220275A Division JP2008069148A (ja)	1996-04-02	2007-08-27	Ｃｄ４＋細胞のｈｉｖ−１感染を防ぐ方法

Publications (2)

Publication Number	Publication Date
JP2000507596A JP2000507596A (ja)	2000-06-20
JP2000507596A5 true JP2000507596A5 (th)	2004-12-09

Family

ID=27417425

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
JP9535610A Withdrawn JP2000507596A (ja)	1996-04-02	1997-04-02	Ｃｄ４▲上＋▼細胞のｈｉｖ―１感染を防ぐ方法
JP2007220275A Withdrawn JP2008069148A (ja)	1996-04-02	2007-08-27	Ｃｄ４＋細胞のｈｉｖ−１感染を防ぐ方法

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
JP2007220275A Withdrawn JP2008069148A (ja)	1996-04-02	2007-08-27	Ｃｄ４＋細胞のｈｉｖ−１感染を防ぐ方法

Country Status (5)

Country	Link
EP (1)	EP0915969A4 (th)
JP (2)	JP2000507596A (th)
AU (1)	AU728512B2 (th)
CA (1)	CA2250829A1 (th)
WO (1)	WO1997037005A1 (th)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6743594B1 (en)	1995-06-06	2004-06-01	Human Genome Sciences, Inc.	Methods of screening using human G-protein chemokine receptor HDGNR10 (CCR5)
US6025154A (en)	1995-06-06	2000-02-15	Human Genome Sciences, Inc.	Polynucleotides encoding human G-protein chemokine receptor HDGNR10
US7118859B2 (en)	1996-01-17	2006-10-10	Progenics Pharmaceuticals, Inc.	Methods for inhibiting HIV-1 infection
US6107019A (en) *	1996-06-14	2000-08-22	Progenics Pharmaceuticals, Inc.	Method for preventing HIV-1 infection of CD4+ cells
US7858298B1 (en)	1996-04-01	2010-12-28	Progenics Pharmaceuticals Inc.	Methods of inhibiting human immunodeficiency virus type 1 (HIV-1) infection through the administration of CCR5 chemokine receptor antagonists
AU3375697A (en)	1996-05-28	1998-01-05	Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The	Cc chemokine receptor 5, antibodies thereto, transgenic animals
DK0910659T3 (da) *	1996-06-03	2006-11-27	United Biomedical Inc	Antistoffer mod et kompleks af CD4 og et kemokin-receptordomæne og anvendelse deraf mod HIV-infektioner
MXPA00003885A (es) *	1997-10-22	2004-04-23	Inst Genetics Llc	Quimiocinas con modificiaciones de la terminacion amino.
FR2771423A1 (fr) *	1997-11-21	1999-05-28	Transgene Sa	Vecteurs permettant d'inhiber ou retarder la liaison d'un virus d'immunodeficience et/ou sa penetration dans une cellule cible
US6399078B1 (en)	1998-06-01	2002-06-04	University Of Maryland Biotechnology Institute	Chemokine—glycosaminoglycan complexes and their use in treating or preventing receptor mediated diseases
AU781934B2 (en) *	1999-07-09	2005-06-23	Gen-Probe Incorporated	Detection of HIV-1 by nucleic acid amplification
US6582920B2 (en)	2000-09-01	2003-06-24	Gen-Probe Incorporated	Amplification of HIV-1 RT sequences for detection of sequences associated with drug-resistance mutations
US7138119B2 (en)	2000-09-15	2006-11-21	Progenics Pharmaceuticals, Inc.	Compositions and methods for inhibition of HIV-1 infection
US7175988B2 (en)	2001-02-09	2007-02-13	Human Genome Sciences, Inc.	Human G-protein Chemokine Receptor (CCR5) HDGNR10
US7060273B2 (en)	2001-04-06	2006-06-13	Progenics Pharmaceuticals, Inc.	Methods for inhibiting HIV-1 infection
US7393934B2 (en)	2001-12-21	2008-07-01	Human Genome Sciences, Inc.	Human G-protein chemokine receptor (CCR5) HDGNR10
US7122185B2 (en)	2002-02-22	2006-10-17	Progenics Pharmaceuticals, Inc.	Anti-CCR5 antibody
WO2005105841A2 (en)	2004-03-12	2005-11-10	Human Genome Sciences, Inc.	Human g-protein chemokine receptor (ccr5) hdgnr10
EP1910573B1 (en)	2005-07-22	2013-09-04	CytoDyn, Inc.	Methods for reducing viral load in hiv-1-infected patients
EP2053060A1 (en) *	2007-10-24	2009-04-29	Protaffin Biotechnologie AG	SDF-1-based glyocosaminoglycan antagonists and methods of using same
AU2014312123A1 (en)	2013-08-29	2016-03-17	Temple University Of The Commonwealth System Of Higher Education	Methods and compositions for RNA-guided treatment of HIV infection

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5440021A (en) *	1991-03-29	1995-08-08	Chuntharapai; Anan	Antibodies to human IL-8 type B receptor
US5504003A (en) *	1994-03-08	1996-04-02	Human Genome Sciences, Inc.	Macrophage inflammatory protein-3 and -4
US6265184B1 (en)	1995-12-20	2001-07-24	Icos Corporation	Polynucleotides encoding chemokine receptor 88C
AU1834197A (en) *	1996-01-30	1997-08-22	National Institutes Of Health, The	Cells expressing both human cd4 and cxcr4
ATE428785T1 (de)	1996-03-01	2009-05-15	Euroscreen Sa	Aktive und inactive cc-chemokinrezeptoren und nukleinsäuremoleküle, die für diesen rezeptor kodieren
FR2748938B1 (fr) *	1996-05-22	1998-07-31	Pasteur Institut	Utilisation de molecules antagonistes de chemokines pour leur activite antivirale notamment contre un retrovirus de type vih

1997
- 1997-04-02 EP EP97917856A patent/EP0915969A4/en not_active Ceased
- 1997-04-02 AU AU26074/97A patent/AU728512B2/en not_active Ceased
- 1997-04-02 WO PCT/US1997/005597 patent/WO1997037005A1/en not_active Ceased
- 1997-04-02 CA CA002250829A patent/CA2250829A1/en not_active Abandoned
- 1997-04-02 JP JP9535610A patent/JP2000507596A/ja not_active Withdrawn
2007
- 2007-08-27 JP JP2007220275A patent/JP2008069148A/ja not_active Withdrawn

Publication	Publication Date	Title
JP2000507119A5 (th)	2004-11-18
JP2000502280A5 (th)	2005-06-16
JP2000510730A5 (th)	2005-01-13
JP2000506431A5 (th)	2005-08-11
JP2000508686A5 (th)	2004-12-09
JP2000508561A5 (th)	2004-11-04
JP2000501771A5 (th)	2004-08-19
JP2000507845A5 (th)	2004-11-18
JP2000512167A5 (th)	2005-01-13
JP2000503342A5 (th)	2005-06-16
JP2000507226A5 (th)	2004-12-02
JP2001501596A5 (th)	2005-04-07
JP2001505643A5 (th)	2005-08-11
JP2000508119A5 (th)	2004-12-09
JP2000505084A5 (th)	2004-11-25
JP2000508949A5 (th)	2004-10-28
JP2002515107A5 (th)	2005-08-11
JP2000508994A5 (th)	2004-12-09
JP2000511425A5 (th)	2005-01-13
JP2000506139A5 (th)	2004-11-25
JP2000511793A5 (th)	2005-02-10
JP2000510098A5 (th)	2004-12-02
JP2000507538A5 (th)	2004-11-04
JP2001501236A5 (th)	2006-05-18
JP2000505908A5 (th)	2005-07-14